These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36655039)
1. Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma. Martins Balbinot K; Almeida Loureiro FJ; Chemelo GP; Alves Mesquita R; Cruz Ramos AMP; Ramos RTJ; da Costa da Silva AL; de Menezes SAF; da Silva Kataoka MS; Alves Junior SM; Viana Pinheiro JJ PeerJ; 2023; 11():e14349. PubMed ID: 36655039 [TBL] [Abstract][Full Text] [Related]
2. Expression of stem cell markers SALL4, LIN28A, and KLF4 in ameloblastoma. de Albuquerque Dias R; Balbinot KM; da Silva Kataoka MS; de Melo Alves Júnior S; de Jesus Viana Pinheiro J Diagn Pathol; 2023 Aug; 18(1):92. PubMed ID: 37559082 [TBL] [Abstract][Full Text] [Related]
3. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells]. Yan ZY; Sun XC Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669 [No Abstract] [Full Text] [Related]
4. Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association. Upadhyay VA; Shah KA; Makwana DP; Raval AP; Shah FD; Rawal RM J Cancer Res Ther; 2020; 16(4):804-810. PubMed ID: 32930122 [TBL] [Abstract][Full Text] [Related]
5. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876 [TBL] [Abstract][Full Text] [Related]
6. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer. You L; Guo X; Huang Y Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774 [TBL] [Abstract][Full Text] [Related]
7. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056 [TBL] [Abstract][Full Text] [Related]
8. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue. Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Cellular Transforming Activity of OCT4, NANOG, and SOX2 in Immortalized Astrocytes. Seo S; Jeon HY; Kim H DNA Cell Biol; 2017 Nov; 36(11):1000-1009. PubMed ID: 28933914 [TBL] [Abstract][Full Text] [Related]
10. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells. Alberti L; Losi L; Leyvraz S; Benhattar J PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma. Destro Rodrigues MF; Sedassari BT; Esteves CM; de Andrade NP; Altemani A; de Sousa SC; Nunes FD J Oral Pathol Med; 2017 Feb; 46(2):112-120. PubMed ID: 27131799 [TBL] [Abstract][Full Text] [Related]
13. Lung adenocarcinoma resistance to therapy with EGFR‑tyrosine kinase inhibitors is related to increased expression of cancer stem cell markers SOX2, OCT4 and NANOG. Hu F; Li C; Zheng X; Zhang H; Shen Y; Zhou L; Yang X; Han B; Zhang X Oncol Rep; 2020 Feb; 43(2):727-735. PubMed ID: 31894290 [TBL] [Abstract][Full Text] [Related]
14. Expression of SOX2, NANOG and OCT4 in a mouse model of lipopolysaccharide-induced acute uterine injury and intrauterine adhesions. Xiao L; Song Y; Huang W; Yang S; Fu J; Feng X; Zhou M Reprod Biol Endocrinol; 2017 Mar; 15(1):14. PubMed ID: 28253866 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Effect of Orlistatorlistat on Expression of OCT4, Nanog, SOX2, and KLF4 Genes in Colorectal Cancer SW40 Cell Line. Noroozi Karimabad M; Roostaei F; Mahmoodi M; Hajizadeh MR Asian Pac J Cancer Prev; 2021 Aug; 22(8):2335-2341. PubMed ID: 34452543 [TBL] [Abstract][Full Text] [Related]
16. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma. Luo W; Li S; Peng B; Ye Y; Deng X; Yao K PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657 [TBL] [Abstract][Full Text] [Related]
17. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma. Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337 [TBL] [Abstract][Full Text] [Related]
18. Tumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathway. Yang J; Liao D; Chen C; Liu Y; Chuang TH; Xiang R; Markowitz D; Reisfeld RA; Luo Y Stem Cells; 2013 Feb; 31(2):248-58. PubMed ID: 23169551 [TBL] [Abstract][Full Text] [Related]
19. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Pierantozzi E; Gava B; Manini I; Roviello F; Marotta G; Chiavarelli M; Sorrentino V Stem Cells Dev; 2011 May; 20(5):915-23. PubMed ID: 20879854 [TBL] [Abstract][Full Text] [Related]
20. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells. Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]